ArticleFrontiers in immunology2025

Type I IFN receptor blockade alleviates liver fibrosis through macrophage-derived STAT3 signaling.

Soo-Jeung Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.